FDA Clears Pfizer Shot for Teens; U.S. Cases Slow: Virus Update
Bloomberg 5 days ago
(Bloomberg)
The U.S. Food and Drug Administration approved the use of Pfizer-BioNTech vaccine for children aged 12 to 15. The number of new cases in U.S. rose last week at the slowest pace since the pandemic began, as more Americans are vaccinated and the nation recovers from a winter spike fueled by holiday travel.
India’s capital of New Delhi extended its lockdown for another week as it battled a wave of infections and warned about a potentially deadly fungal infection in Covid-19 patients. Meanwhile, the World Health Organization sees the highly contagious variant spreading in India as a global concern.
Coronavirus digest: Olympic chief postpones Tokyo trip | News | DW dw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dw.com Daily Mail and Mail on Sunday newspapers.
(FILES) In this file photo taken on November 17, 2020 an illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Johnson & Johnson. – Johnson & Johnson expects to report results from the eagerly-anticipated clinical trial of its Covid-19 vaccine next week, the US pharmaceutical’s chief financial officer told CNBC January 26, 2021. (Photo by JUSTIN TALLIS / AFP)
Germany on Monday opened access to Johnson & Johnson’s coronavirus vaccines to all adults, lifting a priority system determining who gets the jabs first. x
With the majority of people over 60 expected to be already vaccinated by June, Health Minister Jens Spahn said authorities decided not to restrict the jabs to older people over very rare thrombosis risks.